Your browser doesn't support javascript.
loading
Glibenclamide reverses cardiovascular abnormalities of Cantu syndrome driven by KATP channel overactivity.
McClenaghan, Conor; Huang, Yan; Yan, Zihan; Harter, Theresa M; Halabi, Carmen M; Chalk, Rod; Kovacs, Attila; van Haaften, Gijs; Remedi, Maria S; Nichols, Colin G.
Afiliação
  • McClenaghan C; Center for the Investigation of Membrane Excitability Diseases.
  • Huang Y; Department of Cell Biology.
  • Yan Z; Department of Physiology.
  • Harter TM; Center for the Investigation of Membrane Excitability Diseases.
  • Halabi CM; Department of Cell Biology.
  • Chalk R; Department of Physiology.
  • Kovacs A; Center for the Investigation of Membrane Excitability Diseases.
  • van Haaften G; Division of Endocrinology, Department of Medicine, and.
  • Remedi MS; Center for the Investigation of Membrane Excitability Diseases.
  • Nichols CG; Department of Cell Biology.
J Clin Invest ; 130(3): 1116-1121, 2020 03 02.
Article em En | MEDLINE | ID: mdl-31821173

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteocondrodisplasias / Glibureto / Cardiomegalia / Canais KATP / Receptores de Sulfonilureias / Hipertricose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteocondrodisplasias / Glibureto / Cardiomegalia / Canais KATP / Receptores de Sulfonilureias / Hipertricose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2020 Tipo de documento: Article